Former Chief Financial Officer · Evofem Biosciences, Inc. (EVFM)

Justin File

FY2023 is the first fiscal year CompBrief holds for Justin File as a named executive officer of Evofem Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$353,388

Salary $177,905Stock awards $0

3rd of 4 named executive officers at Evofem Biosciences by FY2023 total.

4 named officers on file for Evofem Biosciences, FY2023

Justin File’s pay file — $29

  • 1 fiscal year of pay, line by line
  • EVFM’s disclosed peer group of 24 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Evofem Biosciences’s whole pay program stands against its peers

  • Evofem Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EVFM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 29, 2025 (DEF 14A).

Free

Get Justin File’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Justin File compensation by year

Evofem Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Evofem Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$177,905
Bonus$0
Stock awards$0
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$175,483
Total$353,388

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Evofem Biosciences, Inc. DEF 14A filed October 29, 2025, accession 0001493152-25-020062, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Evofem Biosciences, Inc. filed document, accession 0001493152-25-020062. Every figure is read from that document and cited to the page and table it appears in. Filed October 29, 2025.

Evofem Biosciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Saundra PelletierChief Executive Officer$1,520,455
Ivy ZhangChief Financial Officer and Secretary$438,849
Justin File · this pageFormer Chief Financial Officer$353,388
Katherine AtkinsonFormer Chief Commercial Officer$135,464

The full Evofem Biosciences compensation record

free company brief

This page is one person within Evofem Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Evofem Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Evofem Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Justin File's compensation dossier · One-time report. No refunds.